IMS Health Holdings Company Profile (NYSE:IMS)

About IMS Health Holdings (NYSE:IMS)

IMS Health Holdings logoIMS Health Holdings, Inc. (IMS) is an information and technology services company that provides solutions to its clients in the healthcare industry. The Company has its presence in over 100 countries. The Company's data set contains over 10 petabytes of data and over 500 million patient records. It serves healthcare organizations and life science companies, including pharmaceutical, biotechnology, consumer health and medical device manufacturers, as well as distributors, providers, payers, government agencies, policymakers, researchers and the financial community. The Company's principal information offerings include national information offerings, sub-national information offerings and OneKey. Its technology services offerings include technology solutions, real-world evidence solutions, and workflow analytics and consulting services. It offers technology services that include data warehousing, information technology (IT) outsourcing, software applications and other services.

Industry, Sector and Symbol:
  • Sector: Technology
  • Industry: IT Services & Consulting - NEC
  • Sub-Industry: N/A
  • Symbol: NYSE:IMS
  • CUSIP: N/A
  • Web: www.imshealth.com/
Average Prices:
  • 50 Day Moving Avg: $31.34
  • 200 Day Moving Avg: $30.95
  • 52 Week Range: $23.71 - $31.34
P/E:
  • Trailing P/E Ratio: N/A
  • Foreward P/E Ratio: 17.91
  • P/E Growth: 0.00
Profitability:
  • Net Margins: 2.99%
  • Return on Equity: 5.62%
  • Return on Assets: 1.22%
Debt:
  • Debt-to-Equity Ratio: 2.53%
  • Current Ratio: 1.12%
  • Quick Ratio: 1.12%
Misc:
  • Beta: 0.83
 
Frequently Asked Questions for IMS Health Holdings (NYSE:IMS)

What is IMS Health Holdings' stock symbol?

IMS Health Holdings trades on the New York Stock Exchange (NYSE) under the ticker symbol "IMS."

How were IMS Health Holdings' earnings last quarter?

IMS Health Holdings Inc (NYSE:IMS) posted its quarterly earnings data on Wednesday, July, 27th. The company reported $0.41 EPS for the quarter, beating the Zacks' consensus estimate of $0.38 by $0.03. The business earned $802 million during the quarter, compared to analysts' expectations of $796.93 million. IMS Health Holdings had a return on equity of 5.62% and a net margin of 2.99%. The business's revenue was up 112.4% compared to the same quarter last year. During the same period in the previous year, the business earned $0.37 earnings per share. View IMS Health Holdings' Earnings History.

Who are some of IMS Health Holdings' key competitors?

How do I buy IMS Health Holdings stock?

Shares of IMS Health Holdings can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

What is IMS Health Holdings' stock price today?

One share of IMS Health Holdings stock can currently be purchased for approximately $31.34.


MarketBeat Community Rating for IMS Health Holdings (NYSE IMS)
Community Ranking:  3.1 out of 5 (  )
Outperform Votes:  138 (Vote Outperform)
Underperform Votes:  87 (Vote Underperform)
Total Votes:  225
MarketBeat's community ratings are surveys of what our community members think about IMS Health Holdings and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Analyst Ratings

Consensus Ratings for IMS Health Holdings (NYSE:IMS) (How are Consensus Ratings Calculated?)
Ratings Breakdown: No ratings tracked in the last 12 months.
Consensus Rating:N/A (Score: NaN)
Consensus Price Target: N/A

Analysts' Ratings History for IMS Health Holdings (NYSE:IMS)
Show:
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/12/2016Wells Fargo & CompanyDowngradeOutperform -> Market PerformN/AView Rating Details
5/4/2016Topeka Capital MarketsBoost Price TargetBuy$29.00 -> $30.00N/AView Rating Details
3/24/2016Piper Jaffray CompaniesReiterated RatingOverweight$28.00 -> $32.00N/AView Rating Details
2/23/2016Leerink SwannReiterated RatingOutperformN/AView Rating Details
2/4/2016J P Morgan Chase & CoLower Price Target$38.00 -> $32.00N/AView Rating Details
2/4/2016Barclays PLCLower Price TargetEqual Weight$28.00 -> $26.00N/AView Rating Details
2/2/2016Deutsche Bank AGLower Price TargetBuy$30.00N/AView Rating Details
10/30/2015MizuhoLower Price TargetBuy$36.00 -> $33.00N/AView Rating Details
8/3/2015Stifel NicolausReiterated RatingBuy$32.00 -> $37.00N/AView Rating Details
(Data available from 7/24/2015 forward)

Earnings

Earnings History for IMS Health Holdings (NYSE:IMS)
Earnings by Quarter for IMS Health Holdings (NYSE:IMS)
Earnings History by Quarter for IMS Health Holdings (NYSE IMS)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
7/27/2016Q216$0.38$0.41$796.93 million$802.00 millionViewListenView Earnings Details
5/3/2016Q116$0.38$0.42$749.34 million$774.00 millionViewN/AView Earnings Details
2/3/2016Q415$0.32$0.37$788.75 million$812.00 millionViewN/AView Earnings Details
10/29/2015Q315$0.32$0.38$740.98 million$735.00 millionViewListenView Earnings Details
4/24/2015Q115$0.31$0.38$626.89 million$632.00 millionViewN/AView Earnings Details
2/3/2015Q414$0.32$0.34$679.82 million$678.00 millionViewN/AView Earnings Details
10/24/2014Q314$0.33$0.37$668.30 million$656.00 millionViewListenView Earnings Details
7/24/2014Q1$0.37$0.39$654.92 million$662.00 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)

Estimates

Earnings Estimates for IMS Health Holdings (NYSE:IMS)
Current Year EPS Consensus Estimate: $1.61 EPS
Next Year EPS Consensus Estimate: $1.75 EPS

Dividends

Dividend History for IMS Health Holdings (NYSE:IMS)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trades

Insider Trading and Institutional Ownership History for IMS Health Holdings (NYSE:IMS)
Insider Ownership Percentage: 2.50%
Institutional Ownership Percentage: 90.25%
Insider Trades by Quarter for IMS Health Holdings (NYSE:IMS)
Institutional Ownership by Quarter for IMS Health Holdings (NYSE:IMS)
Insider Trades by Quarter for IMS Health Holdings (NYSE:IMS)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
11/23/2015Kevin C. KnightlySVPSell19,231$28.50$548,083.50View SEC Filing  
11/19/2015Kevin C. KnightlySVPSell55,000$28.37$1,560,350.00View SEC Filing  
5/12/2015Cpp Investment Board Private HMajor ShareholderSell30,554,584$26.68$815,196,301.12View SEC Filing  
4/9/2014Cpp Investment Board Private HMajor ShareholderSell11,990,976$19.10$229,027,641.60View SEC Filing  
4/9/2014John G DanhaklDirectorSell2,463,899$20.00$49,277,980.00View SEC Filing  
(Data available from 1/1/2013 forward)

Headlines

Headline Trends for IMS Health Holdings (NYSE:IMS)
Latest Headlines for IMS Health Holdings (NYSE:IMS)
Source:
DateHeadline
businesswire.com logoQuintilesIMS to Announce Second-Quarter 2017 Results on August 3, 2017
www.businesswire.com - July 20 at 11:39 PM
bizjournals.com logoFortune 500 co. sells Houston health tech co. following revenue slide
www.bizjournals.com - July 19 at 3:26 AM
reuters.com logoEQT to acquire pharmaceutical services firm Certara
www.reuters.com - July 12 at 4:52 AM
News IconEQT nears deal to acquire pharma services firm Certara: sources
www.businessinsider.com - July 12 at 4:52 AM
businesswire.com logoPAVmed Inc. Closes $5 Million Financing
www.businesswire.com - July 6 at 5:55 AM
finance.yahoo.com logoQuintilesIMS may offload contract sales business, says report
finance.yahoo.com - June 22 at 6:13 PM
bloomberg.com logoBiopharma Outsourcing Is Going Through Deal Bonanza in U.S.
www.bloomberg.com - June 21 at 3:36 PM
nasdaq.com logoPamplona Capital to take Parexel private for $4.5 bln
www.nasdaq.com - June 20 at 6:47 PM
reuters.com logoPamplona Capital to take Parexel private for $4.5 billion
www.reuters.com - June 20 at 6:47 PM
americanbankingnews.com logoRackspace Hosting (RAX) & IMS Health Holdings (IMS) Head to Head Review
www.americanbankingnews.com - June 5 at 6:52 PM
streetinsider.com logoQuintilesIMS (Q) Approves Additional $1B Buyback
www.streetinsider.com - May 24 at 5:50 PM
businesswire.com logoQuintilesIMS to Announce First-Quarter 2017 Results on May 3, 2017
www.businesswire.com - April 19 at 5:46 PM
finance.yahoo.com logoNetworkNewsWire Announces Publication of Discussion on the Potential of Immunotherapies for Cancer Treatment
finance.yahoo.com - March 24 at 9:41 AM
bizjournals.com logoCover Story: Inside one of Triangle's hottest industries – CROs
www.bizjournals.com - March 10 at 7:06 PM
bizjournals.com logoQuintilesIMS releases first earnings report as a combined company
www.bizjournals.com - February 14 at 7:17 PM
uk.finance.yahoo.com logoAcademics call time on $100,000 cancer drugs
uk.finance.yahoo.com - February 9 at 6:51 PM
marketwatch.com logoLonza agrees to buy Capsugel in $5.5 billion deal
www.marketwatch.com - December 15 at 4:40 AM
marketwatch.com logoLonza nearing $5 bln deal for KKR's Capsugel
www.marketwatch.com - December 12 at 10:55 AM
wsj.com logoDrug-Research Firm PPD Explores Sale - Wall Street Journal
www.wsj.com - December 9 at 3:32 PM
prnewswire.com logoHealthcare Tech Stocks With Upside Growth Potential - PR Newswire (press release)
www.prnewswire.com - December 1 at 5:57 PM
streetinsider.com logoForm 8-K Quintiles IMS Holdings, For: Nov 29 - StreetInsider.com
www.streetinsider.com - November 30 at 9:35 AM
bizjournals.com logoThe Big Q: Life after Quintiles-IMS merger
www.bizjournals.com - November 25 at 10:51 AM

Social

Chart

IMS Health Holdings (IMS) Chart for Monday, July, 24, 2017

This page was last updated on 7/24/2017 by MarketBeat.com Staff